Pregnant females are ineligible
Female patients who are pregnant are ineligible
Pregnant female patients are not eligible for this study
Female patients who are pregnant are excluded; patients should not be pregnant or plan to become pregnant while on treatment; a pregnancy test prior to enrollment is required for female patients of childbearing potential
Female patients who are pregnant are ineligible
Pregnant women are excluded from this study
Pregnant women are excluded from this study
Pregnant
Pregnant women are excluded from this study
Pregnant women are excluded
Pregnant women
Pregnant women
Male pts must agree to never have unprotected sexual contact with a female who can become pregnant and must agree to either completely abstain from sexual contact with females who are pregnant or are able to become pregnant. The patient must agree to inform his physician if he has had unprotected sexual contact with a female who can become pregnant or if he thinks for any reason that his sexual partner may be pregnant.
TREATMENT: Pregnant
Pregnant women
Pregnant women are excluded from this research; the male partner should use a condom
Patients who are breastfeeding, pregnant, or planning to become pregnant from the time of informed consent until 6 months after the final study dose is administered
Pregnant patients
Pregnant women are excluded from this study
Patients who are pregnant or lactating or who are planning to become pregnant during the course of the study are excluded.
Pregnant women are excluded from this study
Any patient who is pregnant or who may have plans to become pregnant
Pregnant or planning to become pregnant during period of study participation
Pregnant women are excluded from this study
Not pregnant
Women must not be pregnant or breast feeding; pregnant women are excluded from this study
Women known to be pregnant
Women who are pregnant are ineligible.
Pregnant women
Pregnant women
Pregnant women are excluded from this study
Patients who are pregnant
Patients who are pregnant
Pregnant women
Women who are pregnant.
Patients who are pregnant.
Women must not be pregnant or breastfeeding; pregnant women are excluded from this study
Pregnant
Subject is pregnant or trying to become pregnant.
Non-pregnant.
Pregnant women are excluded from this study
Pregnant or breast feeding women; women desiring to become pregnant within the time frame of the study are also excluded
Pregnant women are excluded from this study
Pregnant women are excluded from this study as the proposed treatment has not been well studied in pregnant subjects.
Pregnant women are excluded from this study
Pregnant women are excluded from this study
If you are pregnant, you will not be enrolled on this study
Pregnant women are excluded from this study
Currently pregnant
Pregnancy status will be obtained at time of consent as is routine for all radiation patients; pregnant women are excluded from this study
Patient is known to be pregnant
Patient is pregnant
Pregnant women are excluded from this study
Women who are pregnant
Pregnant women
Pregnant women are excluded
Pregnant women
A pregnant or lactating female or possibly pregnant women, or men or women wishing to have children during the study period;
Pregnant women
Patient is pregnant
Pregnant females are excluded
Women must not be pregnant or breastfeeding; pregnant women are excluded from this study
Pregnant patients will be excluded from this study
Pregnant women are excluded from this study
Pregnant women are excluded from this study
CERITINIB EXCLUSION CRITERIA: Pregnant or nursing women, or women intending to become pregnant during the study (where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive serum hCG laboratory test); pregnant women are excluded from this study; nursing women are excluded unless they discontinue breastfeeding during the study
REGORAFENIB EXCLUSION CRITERIA: Pregnant or nursing women, or women intending to become pregnant during the study (where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive serum hCG laboratory test); pregnant women are excluded from this study; nursing women are excluded unless they discontinue breastfeeding during the study
Women should not become pregnant or breastfeed while on this study
Pregnant women
Pregnant women are excluded from this study
Patients who are pregnant
Pregnant women are excluded from this study
Subjects must not be pregnant
Subjects who are pregnant or may become pregnant
Pregnant women are excluded from this study
Pregnant women are excluded
Are pregnant
Patient is not pregnant
Pregnant women, women planning to become pregnant and women that are nursing
Pregnant women, women planning to become pregnant and women that are nursing
Pregnant women are excluded from this study
Female subjects who are pregnant or planning to become pregnant during the course of SABR
Patients who are pregnant
Females who are pregnant
Pregnant women are excluded from enrollment on this study
Pregnant women
Women who are planning to become pregnant or breast feed during the trial
Pregnant women are not eligible to participate in this study
Women who are pregnant will be excluded (Turnstile II)
Women who are pregnant
Pregnant women, women planning to become pregnant and women that are nursing
Pregnant women are excluded from this study
Women who are pregnant will be excluded (Turnstile II)
Patients who are pregnant
Pregnant women
Females who are pregnant
Pregnant women are excluded from this study
Pregnant women, women planning to become pregnant and women that are nursing
Pregnant women, women planning to become pregnant and women that are nursing
Pregnant
Pregnant women, women planning to become pregnant and women that are nursing
Patients who are pregnant
Patient who is pregnant
Pregnant patients (Cohort D)
Pregnant women are excluded from this study
Pregnant women must not take part in this trial and will be considered as screening failures.
Not pregnant
Pregnant women
DONOR: Pregnant women
Pregnant at time of or within prior year of diagnosis
ENROLLMENT: Pregnant females.
Pregnant women
Not pregnant
Pregnant women
Female patients who are pregnant are ineligible
Female patients who are pregnant are ineligible
Female patients who are pregnant are ineligible
Pregnancy: pregnant women are excluded from this study; should a woman become pregnant or suspect that she is pregnant while participating on the trial, she should inform her treating physician immediately; women who are pregnant or breastfeeding are excluded
Pregnant women
Women must not be pregnant or breastfeeding; pregnant women are excluded from this study
Pregnant women are excluded from this study
Pregnant women are excluded from this study
Pregnant women are excluded from this study
Patients known or found to be pregnant
Female patients who are pregnant are not eligible for this study
Pregnant women
Pregnant patients are ineligible
Women who are pregnant, plan to become pregnant, and/or breastfeed during the study.
Pregnant or nursing women. NOTE: If a woman became pregnant or suspects she is pregnant while participating in this study, she must inform her treating physician immediately.
Not pregnant. Must agree not to become pregnant until at least 6 months after ceasing study treatment
Pregnancy, or planning to become pregnant
Pregnant women
not be pregnant
Pregnant women are excluded from this study
Pregnant female
Pregnant women are excluded from study
Pregnant women are excluded from this study
Female patients who are pregnant are ineligible
Patients who are pregnant
Pregnant
Pregnant or breastfeeding women; women desiring to become pregnant within the timeframe of the study are also excluded.
Pregnant women are excluded from this study
Pregnant patients
Pregnant women are excluded from this study
Pregnant women
Pregnant women
Are not pregnant and do not plan to become pregnant during the clinical trial
Subjects must not be pregnant
Patient is pregnant
Pregnant women are excluded from this study
Patient is pregnant or lactating; pregnant women are excluded from this study
Patient is a pregnant woman
Pregnant women are excluded from this study
Are pregnant
Female patients who are pregnant are not eligible
Pregnant women, women planning to become pregnant and women that are nursing
Pregnant females are excluded
Females who are pregnant
Women who are pregnant
Pregnant women are excluded from this study
Women of child-bearing potential who are pregnant or breastfeeding; additionally, patients that become pregnant while on study protocol will be discontinued immediately
Patient is a pregnant woman (pregnant women are excluded from this study)
Pregnant women are excluded from this study
Pregnant women
Patients who are pregnant
Patients who are pregnant;
The donor is pregnant or lactating, or was pregnant in the previous 6 months, or intends to get pregnant during the study or within 30 days after the last dose of study drug
Pregnant women.
Females who are pregnant
Pregnant women
Pregnant women are excluded from this study
Pregnant women
Pregnant
Pregnant
Pregnant women
Pregnant women
Pregnant or lactating women, or women intending to become pregnant during the study
Pregnant women are excluded from this study
Pregnant women
Pregnant women
Female patients who are pregnant are ineligible
Subjects who are pregnant.
Females: neither pregnant nor intending to become pregnant during the course of the study, defined as:
Pregnant or planning to become pregnant
Pregnancy or planning to become pregnant
Pregnant women are excluded from this study
Women must not be able to become pregnant for the duration of the study.
Pregnant women
Pregnant women are excluded from this study
Pregnant females
Women who are pregnant
Patients who are pregnant
Patients who are pregnant may not be treated on this study
Pregnant women
Nursing or pregnant females; should a woman become pregnant or suspect she is pregnant while participating in the study, she should inform her treating physician immediately
Not pregnant
Women who are pregnant
Pregnant women
Pregnant women are eligible to participate in this study
Pregnant women
Pregnant women
Females who are pregnant
Pregnant participants will not be entered on this study
Subject is pregnant at time of enrollment
Pregnant women
Pregnant women will be excluded
Those who are currently pregnant, have been pregnant within the last 6 months, or are planning to become pregnant in the next 6 months.
YBCS: Women who are pregnant at recruitment will be excluded from this study; however, during the course of follow up, women who become pregnant will be included
Not currently pregnant or planning to become pregnant throughout the duration of cancer treatment
Patient is pregnant
Pregnant women are excluded from this study
Pregnant patients will be excluded
Pregnant women
Non-pregnant females
Pregnant women
Pregnant
Pregnant patients
A positive pregnancy test, currently pregnant or planning to become pregnant in the next three months
Pregnant women
Patients who are pregnant
Pregnant women
Are pregnant
Pregnant
Pregnant
Pregnant
Women who self-report to be pregnant\r\n* As this is an observational study, we will not be performing a pregnancy test, participants will be asked if they are or are not pregnant
Women who are pregnant
Pregnant women
Pregnant
Currently pregnant
Pregnant or thinking about becoming pregnant during the study period
Currently pregnant or planning to become pregnant
Pregnant
Pregnant women
Patients who are pregnant
Women who are pregnant or breastfeeding or planning to become pregnant or breastfeed during the period of treatment and for 112 days following the last dose of sotatercept
Currently pregnant
pregnant
Self-report that they are not pregnant or planning to become pregnant in the next four months
Pregnant females are ineligible; all subjects of childbearing potential will be asked if they are pregnant or could be pregnant; the patient must respond “no” to continue with radiation and to participate in this clinical study
Pregnant
Pregnant or planning to become pregnant during the course of the study
Pregnant
Patients who are pregnant
Pregnant women
Participants who are pregnant
Pregnant patients-excluded by history
Are pregnant or intend to become pregnant during the study period
Pregnant patients
Non-pregnant
Plan to become pregnant in the next two years, as mammography is not typically performed for screening pregnant women
Patients who are currently pregnant
PRELIMINARY TEST: Not currently pregnant or was not pregnant in the last 3 months
Not currently pregnant or was not pregnant in the last 3 months
Pregnant women
Pregnant or possibly pregnant
Currently pregnant
They do not plan to become pregnant during the study; and
Pregnant female
FOR THE 31 SUBJECTS ENROLLED IN YEAR 1: Pregnant female
Pregnant female
Being pregnant
Not pregnant or planning on becoming pregnant
Pregnant women
Pregnant women are naturally excluded given condition of cisplatin therapy
Women who are pregnant
Pregnant or planning to become pregnant within the next year
Pregnant women
Currently pregnant. However, participants enrolled who become pregnant after randomization can remain on the study.
If female, must not be pregnant, plan to become pregnant, or nurse a child during the study and through 30 days after completion of the study
Being pregnant or planning on becoming pregnant within the next year
Pregnant
Pregnant women
Are pregnant
Pregnant women
Pregnant women
Currently pregnant
Pregnant women are excluded from this study
Women who are pregnant or plan to become pregnant in the study period
A women planning to become pregnant, likely to become pregnant or planning to discontinue contraceptive precautions during the vaccination phase of the study, i.e. up to two months after the last vaccine dose.
Pregnant patients
Women on study must be neither pregnant nor nursing nor expected to become pregnant during therapy; for premenopausal women, negative pregnancy test within 14 days of RT is required
Pregnant women
Participants who are pregnant
Pregnant women
Pregnant
Participants who are pregnant
Pregnant women are excluded
Patient is pregnant
Pregnant patients will be included
Are pregnant
Women who are pregnant
Not pregnant
Pregnant patients
Patient is not pregnant
Pregnant patients
Pregnant or lactating women: pregnant women are excluded from this study because the effects of [18F] FAZA in pregnancy are not known. A urine or serum pregnancy test will be performed before accrual after informed consent is obtained.
Men and non-pregnant women.
Pregnant women are excluded from participating in this study
Pregnant women or breastfeeding\r\n* Potential subjects will be asked if they are pregnant; verbal confirmation of pregnancy will be sufficient
The subject is pregnant
Subjects who have contraindications for receiving Y-90 therapy and any routine procedures and imaging associated with Y-90 therapy, including subjects who are pregnant or are planning to become pregnant, will not be eligible to participate in this study. Female subjects who are of childbearing potential should inform her treating physician should she become pregnant at any time during the course of the study
Pregnancy; (pregnant women will be excluded from this study)
Pregnant women are excluded from this study
Pregnant women are excluded
Pregnant women are excluded from this study
Patients who are pregnant or are trying to become pregnant are excluded from this study
Pregnant
Currently pregnant
Participants who are pregnant
Women who are currently pregnant
Pregnant women
Patients who are pregnant
Women who are pregnant
Women who are pregnant or planning to become pregnant during the trial
Pregnant women
Pregnant
Pregnant women are excluded
Is pregnant;
Patients must not be pregnant
Pregnant women
Pregnant women
Patients who are pregnant
Pregnant
Pregnant
Women who are pregnant
Women who are pregnant or trying to get pregnant
Patients who are pregnant
Pregnant patients
Pregnant women are excluded from this study
Females must not be pregnant
Pregnant patients
Not pregnant
Patients who are pregnant are excluded
Pregnant patients are to be excluded
Pregnant women are excluded from participation due to inability to participate in required chemotherapy regimen
Patients who are pregnant
Pregnant women
Patients who are known to be pregnant.
Women who are pregnant will be excluded from the trial
Are pregnant
Pregnant patients
Pregnant
Pregnant
Patients who are pregnant
Women who are pregnant
Be pregnant
Patient who is pregnant
Pregnant women.
Women who are pregnant, intend to become pregnant within 3 months of the study period, or who are breastfeeding
Are pregnant
Patients pregnant at the time of enrollment
Participants who are currently pregnant
Women who are pregnant, intend to become pregnant within 3 months of the study period, or who are breastfeeding
Pregnant patients are excluded
Pregnant women
Not pregnant
PHASE I: Pregnant women will be eligible to participate
Women who are pregnant or intending to become pregnant during the study
Currently pregnant
Pregnant women
Women who are pregnant or lactating, if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus
